BALA MOHAN (SVP, Chief Development Officer) sold 5.1% of their position (3.25K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/15/2025ACC: 0001104659-25-003874
Officer· SVP, Chief Development Officer
Since Sep 2023
-3.25K
Net shares
Net seller
$2.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.75K acquired · 12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.75K
Price / share
—
Trade value
—
% of position
16.0%
1/13/2025
54.73K→63.48K
Common Stock
Direct
Shares
−3.25K
Price / share
$0.66
Trade value
$2.15K
% of position
5.1%
1/14/2025
63.48K→60.23K
Total
Net shares
+5.50K
Net value
-$2.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | M · Option Exercise | +8.75K | — | — | 16.0% | 54.73K | 63.48K |
| Common Stock Direct | 1/14/2025 | S · Sale | −3.25K | $0.66 | $2.15K | 5.1% | 63.48K | 60.23K |
| Total | +5.50K | -$2.15K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
8.75K shares
Shares
−8.75K
Strike price
Held after
17.50K
Exercisable
—
1/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock8.75K shares | 1/13/2025 | M · Option Exercise | −8.75K | — | 17.50K |